 | Syndax Pharmaceuticals, Inc. | |||
| NMS : SNDX || Location: United States | ||||
$21.17+0.6 (+2.94%) |
0.37 M | 20.48 - 21.23 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 9.603 M |
| March 28, 2024 | 9.621 M |
| March 15, 2024 | 8.329 M |
| Feb. 29, 2024 | 9.090 M |
| Feb. 15, 2024 | 8.599 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.81 | -0.73 | 10.03% |
| 06/30/2023 | -0.75 | -0.64 | 14.31% |
| 03/31/2023 | -0.61 | -0.59 | 2.90% |
| 12/31/2022 | -0.66 | -0.62 | 6.30% |
| 09/30/2022 | -0.63 | -0.58 | 7.90% |
SNDX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 84.980M | Shares Float | 84.626M |
| Short Float | 9.603M | Market Cap | 1748.04M |
| Institution ownership | 0.00% | Insider ownership | 0.816% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.98 | Forward EPS | -2.90 |